Evidence map›Paper›PMID 34998411›Full record

ArticleNutrition & metabolism2022

Edible red seaweed Campylaephora hypnaeoides J. Agardh alleviates obesity and related metabolic disorders in mice by suppressing oxidative stress and inflammatory response.

Shigeru Murakami, Chihiro Hirazawa, Rina Yoshikawa, Toshiki Mizutani, Takuma Ohya, Ning Ma, Takahiko Ikemori, Takashi Ito, Chiaki Matsuzaki

Open access · goldAbstract read
In one paragraph

Article in Nutrition & metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Chondroprotective Effect ofInternational journal of molecular sciences · 2024
    Article
  3. Review
  4. Review
  5. Effect ofAntioxidants (Basel, Switzerland) · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Shigeru MurakamiDepartment of Bioscience and Biotechnology, Fukui Prefectural University, Fukui, 9101195, Japan. murakami@fpu.ac.jp.ORCID http://orcid.org/0000-0001-6062-5561
Chihiro HirazawaDepartment of Bioscience and Biotechnology, Fukui Prefectural University, Fukui, 9101195, Japan.
Rina YoshikawaDepartment of Bioscience and Biotechnology, Fukui Prefectural University, Fukui, 9101195, Japan.
Toshiki MizutaniDepartment of Bioscience and Biotechnology, Fukui Prefectural University, Fukui, 9101195, Japan.
Takuma OhyaDepartment of Bioscience and Biotechnology, Fukui Prefectural University, Fukui, 9101195, Japan.
Ning MaDivision of Health Science, Graduate School of Health Science, Suzuka University, Mie, 5100293, Japan.
Takahiko IkemoriIshikawa Prefecture Fisheries Division, Ishikawa, 9208580, Japan.
Takashi ItoDepartment of Bioscience and Biotechnology, Fukui Prefectural University, Fukui, 9101195, Japan.
Chiaki MatsuzakiResearch Institute for Bioscience and Biotechnology, Ishikawa Prefectural University, Ishikawa, 9218836, Japan.
Fukui Prefectural University · JPIshikawa Prefectural University · JPIshikawa Prefecture Archaeological Center · JPSuzuka University · JP

Funding

Fukui Kenritsu Daigaku 01-02R010201
6 · The paper itself

Abstract

backgroundThe obesity epidemic has become a serious public health problem in many countries worldwide. Seaweed has few calories and is rich in active nutritional components necessary for health promotion and disease prevention. The aim of this study was to investigate the effects of the Campylaephora hypnaeoides J. Agardh (C. hypnaeoides), an edible seaweed traditionally eaten in Japan, on high-fat (HF) diet-induced obesity and related metabolic diseases in mice.

methodsMale C57BL/6J mice were randomly divided into the following groups: normal diet group, HF diet group, HF diet supplemented with 2% C. hypnaeoides, and HF diet supplemented with 6% C. hypnaeoides. After 13 weeks of treatment, the weight of the white adipose tissue and liver, and the serum levels of glucose, insulin, adipokines, and lipids were measured. Hepatic levels of adipokines, oxidant markers, and antioxidant markers were also determined. Insulin resistance was assessed by a glucose tolerance test. Polysaccharides of C. hypnaeoides were purified and their molecular weight was determined by high-performance seize exclusion chromatography. The anti-inflammatory effects of purified polysaccharides were evaluated in RAW264.7 cells.

resultsTreatment of HF diet-induced obese mice with C. hypnaeoides for 13 weeks suppressed the increase in body weight and white adipose tissue weight. It also ameliorated insulin resistance, hyperglycemia, hepatic steatosis, and hypercholesterolemia. The ingestion of an HF diet increased serum levels of malondialdehyde (MDA), tumor necrosis factor α (TNF-α), and monocyte chemoattractant protein-1 (MCP-1), while it decreased serum adiponectin levels. In the liver, an HF diet markedly increased the MDA, TNF-α, and interleukin-6 (IL-6) levels, while it decreased glutathione and superoxide dismutase. These metabolic changes induced by HF diet feeding were ameliorated by dietary C. hypnaeoides. Purified polysaccharides and ethanol extract from C. hypnaeoides inhibited the lipopolysaccharide-induced overproduction of nitric oxide and TNF-α in macrophage RAW264.7 cells.

conclusionsThe present results indicated that C. hypnaeoides was able to alleviate HF diet-induced metabolic disorders, including obesity, hyperglycemia, hepatic steatosis, and hypercholesterolemia by attenuating inflammation and improving the antioxidant capacity in mice. Polysaccharides and polyphenols may be involved in these beneficial effects of C. hypnaeoides.

Indexed as

Campylaephora hypnaeoides J. AgardhDiabetesHepatic steatosisInflammationObesityOxidative stressPolysaccharideSeaweed

Identifiers

PMID34998411
PMCPMC8742934
OpenAlexW4221081034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.